@prefix this: <
http://purl.org/np/RALg4jr1hCvhR9N7uzAeV4OnRh280a0qIlnqMF0ZopDPc
> .
@prefix sub: <
http://purl.org/np/RALg4jr1hCvhR9N7uzAeV4OnRh280a0qIlnqMF0ZopDPc#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix bl: <
https://w3id.org/biolink/vocab/
> .
@prefix nkg: <
https://w3id.org/um/neurodkg/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
<
http://purl.obolibrary.org/obo/MONDO_0013600
>
bl:category
bl:Disease
.
sub:association
rdf:object
<
http://purl.obolibrary.org/obo/MONDO_0013600
> ;
rdf:predicate
bl:treats
;
rdf:subject
<
https://go.drugbank.com/drugs/DB00980
> ;
a
rdf:Statement
;
rdfs:label
"Ramelteon is a synthetic melatonin receptor agonist with high affinity for the MT1 and MT2 receptors, and is approved by the FDA for use in adults. Only few case reports have been published in children with NDDs reporting in general limited efficacy on night awakenings" ;
bl:association_type
bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation
;
bl:has_population_context
sub:cohort
;
bl:provided_by
<
https://w3id.org/um/NeuroDKG
> ;
bl:publications
<
https://pubmed.ncbi.nlm.nih.gov/28921528/
> ;
bl:relation
nkg:OffLabelIndication
.
sub:cohort
rdfs:label
"Children" ;
bl:category
bl:Cohort
;
bl:has_phenotype
<
http://purl.obolibrary.org/obo/MONDO_0100038
> .
<
https://go.drugbank.com/drugs/DB00980
>
bl:category
bl:Drug
.
}
sub:provenance
{
sub:assertion
prov:wasAttributedTo
orcid:0000-0002-7641-6446
.
}
sub:pubinfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" ;
npx:hasSignature
"JgxMRWedTOozzP8ZSOKUKZqbwJjQmjkbhdk/7KNBz524L2GvPFt2UPqhcePuduTeF5H1JrSKNPtVZ/NWGdddtTgv/wIGlERUo78wFHbLHqmJYxPdmZe7IYcQydUFle6k7x0IcV24+ttS8vIx+gtZi3kX6DBto+dLN/Kw7KIMDaY=" ;
npx:hasSignatureTarget
this:
.
this:
dct:created
"2021-05-19T20:26:01.809+02:00"^^
xsd:dateTime
;
dct:creator
orcid:0000-0002-7641-6446
;
nt:wasCreatedFromProvenanceTemplate
<
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
> ;
nt:wasCreatedFromPubinfoTemplate
<
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
> ;
nt:wasCreatedFromTemplate
<
http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg
> .
}